AWP
ABBV icon

Atlas Wealth Partners’s AbbVie ABBV Stock Holding History

Atlas Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$221K Hold
1,018
– – 0.23% 61
2025
Q4 		$233K Hold
1,018
– – 0.26% 55
2025
Q3 		$236K Buy
+1,018
New +$207K 0.24% 53
2025
Q2 		– Sell
-1,018
Closed -$213K – 53
2025
Q1 		$213K Buy
+1,018
New +$198K 0.26% 50

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Atlas Wealth Partners's ABBV Position: Q1 2026 in Review

Atlas Wealth Partners held its AbbVie (ABBV) position steady in Q1 2026 at 1,018 shares worth $221K. The position accounts for 0.23% of the portfolio, ranked #61.

Atlas Wealth Partners first reported a position in ABBV in Q1 2025 and has held it in 4 quarters since. The position peaked at $236K in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Atlas Wealth Partners held 1,018 shares of AbbVie worth $221K as of Q1 2026.
  • Atlas Wealth Partners left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.23% of Atlas Wealth Partners's portfolio in Q1 2026, its #61 holding.
  • Atlas Wealth Partners first reported a position in AbbVie in Q1 2025 and has held it in 4 quarters since.
  • Atlas Wealth Partners's AbbVie position peaked at $236K in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Atlas Wealth Partners's 13F filing for Q1 2026, filed 29 Apr 2026.